[{"NetIncomeLoss_3_Q3_USD":-51382000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-236430000.0,"IncomeTaxesPaid_3_Q3_USD":192000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":190000.0,"InventoryFinishedGoods_0_Q3_USD":20217000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":331968000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":6349000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ProceedsFromSaleOfShortTermInvestments_3_Q3_USD":41027000.0,"InterestAndOtherIncome_1_Q3_USD":143000.0,"ProvisionForDoubtfulAccounts_1_Q3_USD":653000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":2181000.0,"OperatingLeaseLiability_0_Q3_USD":27258000.0,"ProductWarrantyAccrual_0_Q3_USD":18193000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":2381000.0,"Liabilities_0_Q3_USD":346444000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1002502000.0,"InterestAndOtherIncome_3_Q3_USD":1235000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-10000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":216000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":8000.0,"ShareBasedCompensation_3_Q3_USD":45123000.0,"Assets_0_Q3_USD":672988000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":335041000.0,"CommonStockSharesIssued_0_Q3_shares":62116000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_3_Q3_USD":85803000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":8710000.0,"ConvertibleDebtNoncurrent_0_Q3_USD":199120000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":29031000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":52762000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":8661000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":6879000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":58290000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":160801000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":50228000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":150385000.0,"AssetsCurrent_0_Q3_USD":592293000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":4386000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":17893000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":129481000.0,"OtherAssetsNoncurrent_0_Q3_USD":10050000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3268000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":61529000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":60568000.0,"InventoryWriteDown_3_Q3_USD":-109000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-69000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":78000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":70000.0,"ProductWarrantyAccrualClassifiedCurrent_0_Q3_USD":6964000.0,"EarningsPerShareBasic_1_Q3_USD":-0.15,"EarningsPerShareBasic_3_Q3_USD":-0.85,"InventoryRawMaterials_0_Q3_USD":36111000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":30687000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":16094000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":46198000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-33000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":383154.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":2314000.0,"ShortTermInvestments_0_Q3_USD":335041000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-1679000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":21325000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-26701000.0,"AccountsReceivableNetCurrent_0_Q3_USD":52104000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-9261000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-51314000.0,"IncreaseDecreaseInInventories_3_Q3_USD":22052000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_3_Q3_USD":34069000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":19906000.0,"FairValueAdjustmentOfWarrants_1_Q3_USD":3648000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":464500000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_3_Q3_USD":19906000.0,"ProductWarrantyAccrualPayments_3_Q3_USD":10217000.0,"ProductWarrantyAccrualNoncurrent_0_Q3_USD":11229000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":305234000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":1704000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":7024000.0,"CommonStockValue_0_Q3_USD":62000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":1446000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":39000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-1938000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-8360000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9963000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3_Q3_USD":700000.0,"InterestExpenseOther_3_Q3_USD":8030000.0,"ProceedsFromWarrantExercises_3_Q3_USD":2935000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":9432000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":12301000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":44521000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-9369000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-53320000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":175000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":37000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.15,"EarningsPerShareDiluted_3_Q3_USD":-0.85,"CommonStockSharesOutstanding_0_Q3_shares":62116000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":278691000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":7820000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":78306000.0,"LeaseCost_1_Q3_USD":1977000.0,"LeaseCost_3_Q3_USD":5767000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-676210000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":60568000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":6233000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":61529000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":9421000.0,"NetIncomeLoss_1_Q3_USD":-9408000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":49320000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1618000.0,"OperatingLeasePayments_3_Q3_USD":5900000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":4916000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":4886000.0,"ShortTermLeaseCost_1_Q3_USD":63000.0,"ShortTermLeaseCost_3_Q3_USD":198000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.059,"GrossProfit_1_Q3_USD":65313000.0,"GrossProfit_3_Q3_USD":169964000.0,"ProductWarrantyAccrualPreexistingIncreaseDecrease_3_Q3_USD":-2902000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5023000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":129481000.0,"AccountsPayableCurrent_0_Q3_USD":20499000.0,"LiabilitiesCurrent_0_Q3_USD":105506000.0,"InventoryWorkInProcess_0_Q3_USD":14316000.0,"DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_0_Q3_USD":85803000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_3_Q3_USD":26011000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":334874000.0,"ProductWarrantyAccrualWarrantiesIssued_3_Q3_USD":14588000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":3464000.0,"OperatingIncomeLoss_1_Q3_USD":-1009000.0,"OperatingIncomeLoss_3_Q3_USD":-26619000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":123603000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":330765000.0,"CommonStockSharesAuthorized_0_Q3_shares":200000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1082000.0,"DeferredFinanceCostsNet_0_Q3_USD":8809000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1881000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":3429000.0,"AccountsReceivableNet_0_Q3_USD":52104000.0,"AccountsReceivableGross_0_Q3_USD":55568000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":5023000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":57677000.0,"InterestExpenseOther_1_Q3_USD":4855000.0,"InventoryNet_0_Q3_USD":70644000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":82709000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":17404000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-2126000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":23312000.0,"StockholdersEquity_0_Q3_USD":326544000.0,"OtherLiabilitiesCurrent_0_Q3_USD":16153000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q3_USD":328000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_3_Q3_USD":2021000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":23925000.0,"ProfitLoss_3_Q3_USD":-51382000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":11022000.0,"OperatingExpenses_1_Q3_USD":66322000.0,"OperatingExpenses_3_Q3_USD":196583000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":9365000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":12837000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":45123000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":30526000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":672988000.0,"OperatingLeaseCost_1_Q3_USD":1914000.0,"OperatingLeaseCost_3_Q3_USD":5569000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":5210000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":4215000.0,"Ticker":"TNDM","CIK":"1438133","name":"TANDEM DIABETES CARE INC","OfficialName":"Tandem Diabetes Care Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"7505811888.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]